Log in

BMV:VOOVVANGUARD ADMIRA/S&P 500 VALUE IX FD Stock Price, Forecast & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A


Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive VOOV News and Ratings via Email

Sign-up to receive the latest news and ratings for VOOV and its competitors with MarketBeat's FREE daily newsletter.

VANGUARD ADMIRA/S&P 500 VALUE IX FD (BMV:VOOV) Frequently Asked Questions

How often does VANGUARD ADMIRA/S&P 500 VALUE IX FD pay dividends? What is the dividend yield for VANGUARD ADMIRA/S&P 500 VALUE IX FD?

VANGUARD ADMIRA/S&P 500 VALUE IX FD declared a quarterly dividend on Monday, December 16th. Stockholders of record on Tuesday, December 17th will be paid a dividend of $0.687 per share on Thursday, December 19th. This represents a $2.75 dividend on an annualized basis and a dividend yield of ∞. The ex-dividend date of this dividend is Monday, December 16th. This is a positive change from VANGUARD ADMIRA/S&P 500 VALUE IX FD's previous quarterly dividend of $0.60. View VANGUARD ADMIRA/S&P 500 VALUE IX FD's dividend history.

Has VANGUARD ADMIRA/S&P 500 VALUE IX FD been receiving favorable news coverage?

News articles about VOOV stock have been trending neutral recently, InfoTrie reports. InfoTrie scores the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. VANGUARD ADMIRA/S&P 500 VALUE IX FD earned a daily sentiment score of 0.2 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news about VANGUARD ADMIRA/S&P 500 VALUE IX FD.

What other stocks do shareholders of VANGUARD ADMIRA/S&P 500 VALUE IX FD own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VANGUARD ADMIRA/S&P 500 VALUE IX FD investors own include Canopy Growth (CGC), JetBlue Airways (JBLU), iShares Edge MSCI USA Momentum Factor ETF (MTUM), PPG Industries (PPG), Alibaba Group (BABA), American Express (AXP), Aphria (APHA), VanEck Vectors Fallen Angel High Yield Bond ETF (ANGL), Ally Financial (ALLY) and AFLAC (AFL).

What is VANGUARD ADMIRA/S&P 500 VALUE IX FD's stock symbol?

VANGUARD ADMIRA/S&P 500 VALUE IX FD trades on the BMV under the ticker symbol "VOOV."

How do I buy shares of VANGUARD ADMIRA/S&P 500 VALUE IX FD?

Shares of VOOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

This page was last updated on 7/11/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.